Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 5.715
-7.97 %
$ 725 M
Market Cap
-571.5
P/E
ORGO - COST OF REVENUE
Cost of Revenue ORGO - Organogenesis Holdings Inc.
106 M
LAST VALUE
-3.44%
2 YEAR CAGR
9.13%
5 YEAR CAGR
0.00%
10 YEAR CAGR